all - Opinion Summaries
Page 79 of 88
Showing Result 781 - 790 of 874
| Description | Date | Docket # |
|---|---|---|
GOLDENBERG v. CYTOGEN, INC.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn a medical patent case concerning Tumor Localization and Therapy, the court affirmed summary judgment for defendants on literal infringement claims,... |
06/23/2004 | 03-1409 |
XECHEM INC. v. BRISTOL MYERS SQUIBB CO.United States Seventh Circuit
Antitrust & Trade Regulation, Civil Procedure, Drugs & BiotechPlaintiff's antitrust case concerning prescription drugs could not be dismissed as untimely, because the statutory period runs from the most recent... |
06/23/2004 | 03-4292 |
METABOLITE LABS., INC. v. LAB. CORP. OF AM. HOLDINGSUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn patent claim concerning a method for detecting B12 and folic acid deficiency, district court did not err in awarding enhanced damages for willful... |
06/08/2004 | 03-1120 |
IN RE DIET DRUGSUnited States Third Circuit
Class Actions, Drugs & Biotech, Injury & Tort LawUnder the All Writs Act U.S.C. section 1651, the District Court has the power to supervise the actions of intermediate opt-out class members in... |
05/25/2004 | 02-4582 |
EHLIS v. SHIRE RICHWOOD, INC.United States Eighth Circuit
Drugs & Biotech, Injury & Tort Law, Product LiabilityDistrict court properly ruled North Dakota would adopt the "learned intermediary" doctrine, and that application of the doctrine barred plaintiffs'... |
05/18/2004 | 02-3933, 03-1057 |
INNOMED LABS, LLC v. ALZA CORP.United States Second Circuit
Antitrust & Trade Regulation, Contracts, Drugs & Biotech, Intellectual Property, PatentWhere defendant was accused of price discrimination in the distribution of its patented drug, neither the jury instruction regarding whether the... |
05/14/2004 | 02-9491 |
E.T. HORN CO. v. USUnited States Federal Circuit
Drugs & Biotech, International TradeThe Harmonized Tariff Schedule of the US seeks the classification of ethers according to their structural relationship to their respective alcohols by... |
05/12/2004 | 03-1363 |
HOUSEY PHARMS., INC. v. ASTRAZENECA UK LTD.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentPlaintiff's patent, concerning a method of screening for protein inhibitors or activators, was properly deemed invalid. Judgment of noninfringement is... |
05/07/2004 | 03-1193, 03-1210 |
ELAN CORP., PLC v. ANDRX PHARMS., INC.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentDistrict court erred in declaring plaintiff's patent invalid under the on-sale bar of 35 U.S.C. section 102(b). Plaintiff did not offer to sell its... |
05/05/2004 | 03-1354, 03-1355, 03-1386, 03-1387 |
SMITHKLINE BEECHAM CORP. v. APOTEX CORP.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentJudgment of non-infringement is affirmed because the public use bar of 35 U.S.C. section 102(b) renders claim 1 of plaintiff's patent for an... |
04/23/2004 | 03-1285, 03-1313 |
Results 781 to 790 of 874